The University of California San Diego takes the stage in many programs — its Department of Theatre and Dance easily commanding the spotlight. Ranked among the top five acting programs in the world by Hollywood Reporter, the department’s students graduate well-prepared for the theater profession. Cast with experience — due in part to a dynamic partnership with its acclaimed neighbor, La Jolla Playhouse — UC San Diego graduates consistently take the lead in television, film and stage careers. Proof positive are three recent Tony Award nominations earned by alumni Michael Greif (MFA directing, ’85), nominated for Best Direction of a Musical, “Dear Evan Hansen;” Jefferson Mays (MFA acting, ’91), nominated for Best Actor in a Leading Role in a Play, “Oslo;” and Paloma Young (MFA, costume design, ’06), nominated for Best Costume Design of a Musical, “Natasha, Pierre, and the Great Comet of 1812.”
Engineers at UC San Diego are using soft robotics technology to make light, flexible gloves that allow users to feel tactile feedback when they interact with virtual reality environments. The researchers used the gloves to realistically simulate the tactile feeling of playing a virtual piano keyboard.
One-third of American children are overweight or obese. Family-based treatment (FBT) has been considered the best model for the treatment of obese children as it provides both parents and children with education and behavior therapy techniques but is provided mainly in a hospital setting. Researchers at University of California San Diego School of Medicine have found that parent-based therapy (PBT) has similar outcomes to FBT and could be more cost-effective.
Unusually warm nights can harm human sleep, researchers show, and the poor and the elderly are most affected. Rising temperatures could make sleep loss more severe.
The diversity and talent of graduating University of California San Diego artists is currently highlighted in “A Step Away: Artists from the M.F.A. Program at UC San Diego,” an exhibition showing through May 29 at the Museum of Contemporary Art, San Diego (MCASD).
In a small, randomized Phase I/II clinical trial (SAT1), researchers at University of California San Diego School of Medicine say a 100-year-old drug called suramin, originally developed to treat African sleeping sickness, was safely administered to children with autism spectrum disorder (ASD), who subsequently displayed measurable, but transient, improvement in core symptoms of autism.
